Skip to main content
. 2019 Aug 30;14(8):e0214776. doi: 10.1371/journal.pone.0214776

Table 2. Baseline information according to self-reported daytime napping.

Daytime napping, h ALL n = 33850 0 n = 22457 (0, 1] n = 8240 (1, 1.5] n = 1817 >1.5 n = 1336 P value
Age, years 58.1±9.3 57.3±8.9 59.8±9.7 59.7±9.6 59.5±9.8 <0.001
Male, % 33.1(11198) 31.2(7001) 35.9(2960) 41.8(759) 35.8(478) <0.001
Waist circumference, cm 86.2±10.0 86.2±10.1 86.0±9.8 86.7±10.1 87.3±10.4 <0.001
Hip circumference, cm 97.0±7.8 97.0±7.9 96.8±7.6 97.2±7.8 97.4±7.8 0.042
BMI, kg/m2 24.7±3.7 24.7±3.7 24.4±3.6 24.8±3.8 25.1±3.8 <0.001
Tumor, % 2.9(992) 3.1(698) 2.6(212) 3.2(58) 1.8(24) 0.004
Diabetes, % 22.8(7712) 20.7(4657) 25.3(2084) 29.8(541) 32.2(430) <0.001
Smoking habits <0.001
Regular smoker, % 12.6(4219) 12.3(2745) 12.1(996) 16.3(291) 14.2(187)
Sometimes smoker, % 2.6(878) 2.5(553) 2.9(236) 2.9(52) 2.8(37)
Never smoker, % 84.8(28470) 85.2(18961) 85.0(6969) 80.8(1443) 83.0(1097)
Drinking habits <0.001
Regular drinker, % 7.0(2349) 6.8(1507) 6.8(559) 9.8(175) 8.1(108)
Sometimes drinker, % 19.1(6406) 19.1(4242) 18.9(1554) 20.3(363) 18.6(247)
Never drinker, % 73.9(24827) 73.5(16512) 74.3(6095) 69.9(1247) 73.3(973)
Regular exercise, % 12.1(4097) 13.3(2972) 9.7(802) 9.5(173) 11.2(150) <0.001
Exercise intensity <0.001
Mild exercise, % 9.1(3081) 10.0(2251) 7.5(620) 5.8(106) 7.8(104)
Moderate exercise, % 2.6(875) 2.8(618) 1.9(158) 3.4(61) 2.8(38)
Severe exercise, % 0.4(141) 0.5(103) 0.3(24) 0.3(6) 0.6(8)
Obesity(BMI> = 28), % 15.1(5127) 15.7(3515) 13.3(1092) 15.9(289) 17.3(231) <0.001
HbA1c, % 5.9(5.6,6.2) 5.8(5.6,6.2) 5.9(5.6,6.3) 6.0(5.6,6.4) 6.0(5.6,6.5) <0.001
SBP, mmHg 131.8±20.4 132.1±20.6 131.4±20.0 131.6±20.2 131.1±19.7 0.034
DBP, mmHg 77.6±10.9 77.8±11.0 77.1±10.6 77.9±10.7 77.3±10.8 <0.001
Hypertension, % 60.3(20403) 60.2(13530) 59.8(4926) 62.6(1137) 60.6(810) <0.001
CreaC, mmol/L 65.8(59.5,73.7) 65.2(59.1,72.9) 66.9(50.4,75.3) 66.9(60.1,77.8) 66.4(60.0,74.2) <0.001
Triglycerides, mmol/L 1.36(0.97,1.97) 1.32(0.95,1.92) 1.45(1.03,2.06) 1.43(1.03,2.08) 1.49(1.04,2.10) <0.001
Cholesterol, mmol/L 5.07±1.13 5.16±1.13 4.88±1.11 4.95±1.16 4.85±1.10 <0.001
HDL, mmol/L 1.32±0.34 1.34±0.34 1.26±0.33 1.26±0.34 1.25±0.33 <0.001
LDL, mmol/L 2.98±0.90 3.06±0.90 2.83±0.87 2.87±0.88 2.79±0.85 <0.001
GGT, mmol/L 21.0(15.0,32.0) 21.0(15.0,32.0) 20.0(15.0,31.8) 22.0(15.0,34.0) 21.0(15.0,33.0) <0.001
AST, mmol/L 20.0(17.0,25.0) 20.0(17.0,25.0) 20.0(17.0,25.0) 20.0(17.0,25.0) 21.0(17.0,25.0) 0.862
ALT, mmol/L 15.0(11.0,21.0) 15.0(11.0,21.0) 15.0(11.0,21.0) 14.0(11.0,20.0) 15.0(11.0,21.0) 0.715
FBG, mmol/L 5.55(5.12,6.19) 5.52(5.12,6.11) 5.57(5.10,6.26) 5.65(5.20,6.40) 5.70(5.21,6.50) <0.001
PBG, mmol/L 7.40(6.01,9.73) 7.24(5.95,9.44) 7.62(6.10,10.10) 8.00(6.46,10.89) 8.23(6.50,11.10) <0.001
Total sleep duration, h 8.1±1.2 7.8±1.1 8.5±1.0 9.2±1.1 9.8±1.2 <0.001
Microalbuminuria, % 14.5(4905) 12.2(2742) 19.3(1589) 16.8(305) 20.1(269) <0.001
High UACR level, % 24.7(8357) 24.2(5434) 24.8(2045) 27.5(500) 28.3(378) <0.001
CKD, % 2.5(832) 2.3(510) 2.6(216) 3.6(65) 3.1(41) 0.001
Hyperfilitration, % 2.5(860) 2.3(517) 2.7(226) 3.7(68) 3.7(49) <0.001
UACR, mg/g 10.0(5.8,19.9) 8.7(5.3,16.9) 13.7(7.7,25.3) 11.3(6.2,22.0) 12.8(7.1,26.5) <0.001
eGFR, ml/(min×1.73m2 93.9±19.1 94.3±18.5 94.3±18.6 93.8±21.2 93.8±20.2 <0.001

Chi-squared tests for discrete variables and one-way ANOVA for continuous variables.

All continuous variables with normal distribution are presented as the mean values and standard deviation (SD). All continuous variables with skewness distribution are presented as media and 25,75 percentile. All enumeration data presented as proportion.

Microalbuminuria was defined as UACR> = 30 mg/g, CKD was defined as eGFR<60 ml/min and hyperfiltration was defined as eGFR> = 135 ml/min.

According to the quartile division, among which centre the subjects belonged, the UACR data were divided into the under 25% group, the 25%-50% group, the 50%-75% group, and the over 75% group. Higher UACR level was defined as subjects belonged to the over 75% group.